The medicinal treatment of COVID-19: a brief update

Mark G J de Boer*, Emilie M Gieling, Paul D van der Linden, Bhanu N M Sinha, Albert M Vollaard

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Much has changed in the medical treatment of COVID-19 after the first patient with an infection with SARS-CoV-2 in the Netherlands was diagnosed in February 2020. On the basis of limited data, at first only off-label use of (hydroxy)chloroquine seemed to be a treatment option. However, now based on the findings of several randomized studies, other medicines have been included in the Dutch guidelines about the treatment of COVID-19. In this article, we will briefly discuss the current state of affairs with regard to the drugs (hydroxy) chloroquine, remdesivir and corticosteroids. Again, it appears that only well-executed randomized clinical trials can determine the status of various supposedly effective drugs.

Translated title of the contributionThe medicinal treatment of COVID-19: a brief update
Original languageDutch
Article numberD5620
Number of pages4
JournalNederlands Tijdschrift voor Geneeskunde
Volume164
Publication statusPublished - 12-Nov-2020

Cite this